Cloud Computation Methods to Accelerate Breast Cancer Drug Discovery through Molecular Modeling

The integration of cloud computing technologies with molecular modeling approaches has revolutionized the landscape of breast cancer drug discovery. The article examines the levels of impact that cloud computing would have had in speeding breast cancer-specific therapeutic compound discovery, virtual screening, and optimization. Using distributed computing frameworks, researchers can now conduct sophisticated molecular simulations, quantum calculations and machine learning algorithms many times faster than earlier. This paper explores a range of cloud computation methods used in breast cancer work, including infrastructure-as-a-service solutions, container systems, and molecular modeling tools adapted for cloud environments. It is evident that computational efficiency gains emerged; the investigation demonstrated significant drops on time spent for molecular docking, molecular dynamics simulations, and QSAR investigations. Furthermore, the research highlights how cloud-based collaborative tools improve inter-team data exchange, resulting in accelerated breast cancer therapy developments from target identification to lead optimization. The development of tailored breast cancer therapies has a lot to gain from innovations in cloud-based multi-omics methods. By extensively analysing the use of the cloud to compute in breast cancer drug discovery, this investigation shows tremendous speed-acceleration possibilities using modern technologies such as quantum computing and federated learning systems.